clobenpropit has been researched along with Cancer of Testis in 1 studies
clobenpropit: histamine H3 receptor antagonist
clobenpropit : An imidothiocarbamic ester that consists of isothiourea bearing S-3-(imidazol-4-yl)propyl and N-4-chlorobenzyl substituents. An extremely potent histamine H3 antagonist/inverse agonist (pA2 = 9.93). Also displays partial agonist activity at H4 receptors; induces eosinophil shape change with an EC50 of 3 nM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abiuso, AMB | 1 |
| Varela, ML | 1 |
| Haro Durand, L | 1 |
| Besio Moreno, M | 1 |
| Marcos, A | 1 |
| Ponzio, R | 1 |
| Rivarola, MA | 1 |
| Belgorosky, A | 1 |
| Pignataro, OP | 1 |
| Berensztein, E | 1 |
| Mondillo, C | 1 |
1 other study available for clobenpropit and Cancer of Testis
| Article | Year |
|---|---|
Histamine H4 receptor as a novel therapeutic target for the treatment of Leydig-cell tumours in prepubertal boys.
Topics: Age Factors; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Aromatase; Cell Line, Tumor; C | 2018 |